By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

437 South Highway 101
Suite 209
Solana Beach  California    U.S.A.
Phone: 858-433-2800 Fax: n/a



Company News
Imprimis Pharmaceuticals (immy) To Ring The Nasdaq Stock Market Closing Bell 7/1/2015 10:37:52 AM
Imprimis Pharmaceuticals (immy) Acquires Proprietary Compounded Conscious Sedation Formulations 6/23/2015 6:56:48 AM
Imprimis Pharmaceuticals (immy) Announces First Quarter 2015 Financial Results And Provides Business Update 5/14/2015 7:04:48 AM
Imprimis Pharmaceuticals (immy) Announces $15 Million Term Loan Agreement With Life Sciences Alternative Funding LLC 5/12/2015 7:21:33 AM
Imprimis Pharmaceuticals (immy) To Launch Its New Hep-Lido-A And Lyophilized Tri-Mix Compounded Formulations At The American Urological Association Annual Meeting In New Orleans 5/8/2015 11:14:44 AM
Imprimis Pharmaceuticals (immy) To Host Its First Quarter 2015 Financial Report Conference Call And Webcast On May 13, 2015 At 4:30 P.M. EDT 5/4/2015 11:41:10 AM
Imprimis Pharmaceuticals (immy) Now Has Exclusive US Commercial Rights To Patented Hep-Lido-A Formulation For Interstitial Cystitis 4/28/2015 6:39:33 AM
Imprimis Pharmaceuticals (immy)' Ophthalmic Formulations To Be Presented At The 2015 American Society of Cataract & Refractive Surgery Symposium And Congress 4/15/2015 2:56:39 PM
Imprimis Pharmaceuticals (immy) Announces 2015 Annual Meeting Of Stockholders 4/2/2015 6:59:56 AM
Imprimis Pharmaceuticals (immy) Announces Fourth Quarter And Year-End 2014 Financial Results And Provides Business Update 3/13/2015 7:43:49 AM